Market Cap 739.98M
Revenue (ttm) 0.00
Net Income (ttm) -43.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,054,003
Avg Vol 1,131,786
Day's Range N/A - N/A
Shares Out 85.89M
Stochastic %K 39%
Beta 0.83
Analysts Sell
Price Target $34.33

Company Profile

Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in the development of novel therapeutics for the treatment of neurodegenerative, neurodevelopmental, and neuropsychiatric disorders, including Alzheimer's disease, Parkinson's disease, schizophrenia, Rett syndrome, and other central nervous system (CNS) diseases, pain, and various types of cancer. Its lead drug candidate, ANAVEX 2-73 (blarcamesine), which has completed a Phase 2a and a Phase 2b/3 clinical trial for Al...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 689 3939
Address:
630 5th Avenue, 20th Floor, New York, United States
papatrick
papatrick Oct. 27 at 9:00 PM
$AVXL pure FUDster...Where is Georgjj now? this is a FUDster Georgjj ..not longs tired of waiting. This is lying!
0 · Reply
Logic102
Logic102 Oct. 27 at 8:33 PM
$AVXL We know that we have a far superior drug to the current Standard of Care approved, profit making ones in Leqembi and Kisunla. That will eventually pay off in a big way. When? That is the question.
1 · Reply
JV716
JV716 Oct. 27 at 8:10 PM
$AVXL 100%!!! Look at the Price Action!!! Better be prepared than Sorry!!! CITADEL is unstoppable.
1 · Reply
Georgejj
Georgejj Oct. 27 at 8:03 PM
$AVXL AVXL stock price is down 12 cents with over one million shares bought today!!! Good luck and GOD bless,
0 · Reply
rgates1940
rgates1940 Oct. 27 at 7:57 PM
$AVXL Be prepared for a disappointment if we get approval from EMA. I have seen this once before. The SHORTS will attempt to crush this company in the face of good news in an effort to salvage themselves and completely discourage all of us LONGS. Only a buyout will solve this issue.
7 · Reply
keyeaster
keyeaster Oct. 27 at 7:54 PM
$AVXL Two weeks from today we'll see the Nov. chmp agenda. There are three possibilities. 1 We are on the 2-1 Pre-authorisation procedure oral explanation list. 2 We are on the 3-1 Initial applications, opinions list. Or 3 No mention of blarcamesine at all.My bet is numder 2.
0 · Reply
lronhoj
lronhoj Oct. 27 at 7:46 PM
$AVXL @Robertupstate not really. If you’d been here for years you know what to expect. The only thing that matters is approval and revenue. Everything else is just noise. Unless you want to add more, then send a kind thank you to the market manipulators. Just wait. Time will deal with the fuckery.
0 · Reply
Factanonverba
Factanonverba Oct. 27 at 7:39 PM
$AVXL Ulla Wändel Liminga is heading the chair of Pharmacovigilance Risk Assesment Commitee (PRAC). On 10/20 they published meeting minutes blarc being in preD-180 scope https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-1-4-september-2025_en.pdf The Swedish regional health authorities published a report on blarc in June this year which was cautiously optimistic. The authorities recognize real disease-modifying potential and a major convenience/safety advantage, but they also emphasize: Early stage evidence is not yet definitive, Clinical magnitude at 48 weeks is borderline, Long-term benefit is promising but needs final confirmation - nothing new. http://samverkanlakemedel.se/download/18.6be0dfcb19937114a3a571b/1758861823320/Blarkamesin-vid-Alzheimers-sjukdom-tidig-bedomningsrapport-250619.pdf That's after UK, DK, NL pre-registration activities with the governement for reimbursement as discussed yesterday and today on this board. Most countries cannot before approval. Norway also has blarc on the radar https://www.nyemetoder.no/4a79df/contentassets/55df15e45e2a4e9083a95e751a772ff7/2025/nye-legemidler-som-ikke-har-mt--september-2025.pdf Italy too https://www.aifa.gov.it/documents/20142/1108722/Horizon_Scanning_2025.pdf?utm_source=chatgpt.com
3 · Reply
Robertupstate
Robertupstate Oct. 27 at 7:35 PM
$AVXL very discouraging. Makes you wonder if someone knows something or the assumption is denial/additional trials. May need to eat the losses.
0 · Reply
Cresskill198
Cresskill198 Oct. 27 at 7:26 PM
$AVXL Only one red stock while the entire market’s been blazing green all year long? Yeah, I’m sure that’s just a wild coincidence. Nothing intentional whatsoever. Puhahaha!
0 · Reply
Latest News on AVXL
Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call Transcript

Aug 12, 2025, 10:38 AM EDT - 2 months ago

Anavex Life Sciences Corp. (AVXL) Q3 2025 Earnings Call Transcript


Does Anavex's Alzheimer's Drug Actually Confer Benefit?

May 15, 2025, 8:49 PM EDT - 5 months ago

Does Anavex's Alzheimer's Drug Actually Confer Benefit?


Playing The Odds Of Anavex Alzheimer's Drug Approval

Jan 12, 2025, 11:21 AM EST - 10 months ago

Playing The Odds Of Anavex Alzheimer's Drug Approval


Anavex Life Sciences: Why I Am Still Not Buying The Bull Thesis

Dec 24, 2024, 8:50 AM EST - 10 months ago

Anavex Life Sciences: Why I Am Still Not Buying The Bull Thesis


Anavex Life Sciences Corp. (AVXL) Q4 2024 Earnings Call Transcript

Dec 23, 2024, 10:23 AM EST - 11 months ago

Anavex Life Sciences Corp. (AVXL) Q4 2024 Earnings Call Transcript


papatrick
papatrick Oct. 27 at 9:00 PM
$AVXL pure FUDster...Where is Georgjj now? this is a FUDster Georgjj ..not longs tired of waiting. This is lying!
0 · Reply
Logic102
Logic102 Oct. 27 at 8:33 PM
$AVXL We know that we have a far superior drug to the current Standard of Care approved, profit making ones in Leqembi and Kisunla. That will eventually pay off in a big way. When? That is the question.
1 · Reply
JV716
JV716 Oct. 27 at 8:10 PM
$AVXL 100%!!! Look at the Price Action!!! Better be prepared than Sorry!!! CITADEL is unstoppable.
1 · Reply
Georgejj
Georgejj Oct. 27 at 8:03 PM
$AVXL AVXL stock price is down 12 cents with over one million shares bought today!!! Good luck and GOD bless,
0 · Reply
rgates1940
rgates1940 Oct. 27 at 7:57 PM
$AVXL Be prepared for a disappointment if we get approval from EMA. I have seen this once before. The SHORTS will attempt to crush this company in the face of good news in an effort to salvage themselves and completely discourage all of us LONGS. Only a buyout will solve this issue.
7 · Reply
keyeaster
keyeaster Oct. 27 at 7:54 PM
$AVXL Two weeks from today we'll see the Nov. chmp agenda. There are three possibilities. 1 We are on the 2-1 Pre-authorisation procedure oral explanation list. 2 We are on the 3-1 Initial applications, opinions list. Or 3 No mention of blarcamesine at all.My bet is numder 2.
0 · Reply
lronhoj
lronhoj Oct. 27 at 7:46 PM
$AVXL @Robertupstate not really. If you’d been here for years you know what to expect. The only thing that matters is approval and revenue. Everything else is just noise. Unless you want to add more, then send a kind thank you to the market manipulators. Just wait. Time will deal with the fuckery.
0 · Reply
Factanonverba
Factanonverba Oct. 27 at 7:39 PM
$AVXL Ulla Wändel Liminga is heading the chair of Pharmacovigilance Risk Assesment Commitee (PRAC). On 10/20 they published meeting minutes blarc being in preD-180 scope https://www.ema.europa.eu/en/documents/minutes/minutes-prac-meeting-1-4-september-2025_en.pdf The Swedish regional health authorities published a report on blarc in June this year which was cautiously optimistic. The authorities recognize real disease-modifying potential and a major convenience/safety advantage, but they also emphasize: Early stage evidence is not yet definitive, Clinical magnitude at 48 weeks is borderline, Long-term benefit is promising but needs final confirmation - nothing new. http://samverkanlakemedel.se/download/18.6be0dfcb19937114a3a571b/1758861823320/Blarkamesin-vid-Alzheimers-sjukdom-tidig-bedomningsrapport-250619.pdf That's after UK, DK, NL pre-registration activities with the governement for reimbursement as discussed yesterday and today on this board. Most countries cannot before approval. Norway also has blarc on the radar https://www.nyemetoder.no/4a79df/contentassets/55df15e45e2a4e9083a95e751a772ff7/2025/nye-legemidler-som-ikke-har-mt--september-2025.pdf Italy too https://www.aifa.gov.it/documents/20142/1108722/Horizon_Scanning_2025.pdf?utm_source=chatgpt.com
3 · Reply
Robertupstate
Robertupstate Oct. 27 at 7:35 PM
$AVXL very discouraging. Makes you wonder if someone knows something or the assumption is denial/additional trials. May need to eat the losses.
0 · Reply
Cresskill198
Cresskill198 Oct. 27 at 7:26 PM
$AVXL Only one red stock while the entire market’s been blazing green all year long? Yeah, I’m sure that’s just a wild coincidence. Nothing intentional whatsoever. Puhahaha!
0 · Reply
bartwood
bartwood Oct. 27 at 7:17 PM
$AVXL Bullish as hell! 💪💪
0 · Reply
LongOrShortToMakeMoney
LongOrShortToMakeMoney Oct. 27 at 7:09 PM
$AVXL just terrible
1 · Reply
kitty7kitty
kitty7kitty Oct. 27 at 6:55 PM
$AVXL Me, too, just added another 500, thanks shorts.
2 · Reply
Filldagap
Filldagap Oct. 27 at 6:52 PM
$AVXL Question: Does anyone have any information on the licensing of Blarcamesine with the NMPA in China? Cases have more than tripled since the early 90's and risen more than the global average. I believe that the age 60+ folks is growing faster than other groups within as well. Interesting.
0 · Reply
DueBill
DueBill Oct. 27 at 6:51 PM
$AVXL so who thinks a Muslim Socialist Democrat who has HUGE transformation plans for New Yorkers… including shaking down (again) rich people to pay for it. If he does bull shit his way into their hearts and minds… I’ll be flying those rich folk out of TEB Teterboro to South Florida after the election. Permanently. I’ve been flying that route for the last week. Lots of hand wringing in the back.😂 Democrats have to be shaking their heads … WTF 🤦‍♂️ My father who was a democrat convention delegate would be crapin his pants. So it comes down to to who votes more… the people getting the free stuff or the people paying for the free stuff??? Nothing is free. Someone has to pay.
3 · Reply
Georgejj
Georgejj Oct. 27 at 6:51 PM
$AVXL AVXL has shown clinical benefits for a lot of trial participants so far. https://m.youtube.com/watch?v=8orzf4UXNLA Good luck and GOD bless,
0 · Reply
Blarcamesine
Blarcamesine Oct. 27 at 6:49 PM
$AVXL wow!! Short madness.. just need a positive opinion from chmp!!
0 · Reply
Stoneage823
Stoneage823 Oct. 27 at 6:48 PM
$AVXL just added 500 at $8.40 thanks shorts! 😂🤩
0 · Reply
cy390
cy390 Oct. 27 at 6:37 PM
$AVXL it's all so tiresome. also, this guy lends his shares to shorts.
2 · Reply
Itinerant
Itinerant Oct. 27 at 6:33 PM
$AVXL I think that the market manipulators know that the jig is up and they will continue to do everything possible to scare every retail held share loose for their short covering and institutional buyer friends. This will continue until the very day that the CHMP announces its positive approval. Hold on tight and grin and bear it. That is my opinion. I hope to God that I am right for me and all of us. God bless Chris Missling.
2 · Reply
redbugs
redbugs Oct. 27 at 6:27 PM
$AVXL GETS TIRESOME DOESNT IT??
0 · Reply
greedo
greedo Oct. 27 at 6:26 PM
$AVXL @SCLXSUX @danielkazado Where you boys is today? Too busy buying up cheapies for our last opportunity at these prices?
0 · Reply